MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹585.7 Cr | 0.4% | 4.2% | 27.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,668.1 Cr | 2.7% | -2.5% | -30.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,095.6 Cr | -4.5% | -12.6% | 12.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,541.6 Cr | 5.6% | 0.3% | 37.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹923.5 Cr | 1.8% | -7.4% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹256.6 Cr | -3.6% | -2.4% | -19.1% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 0.4% |
4.2% |
27.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses